Hemostasis Valves Market by Technology Advancement and Future Outlook 2019 - 2027

Transparency Market Research (TMR) has published a new report on the global hemostasis valves market for the forecast period of 2019–2027. According to the report, the global hemostasis valves market was valued at ~US$ 135 Mn in 2018, and is projected to expand at a CAGR of 4.5% from 2019 to 2027. Increase in awareness about the early diagnosis of chronic diseases and rise in the number of angiography procedures are boosting the global hemostasis valves market.

Increase in Number of Neuroendovascular Procedures to Propel Market

• The prevalence of coronary diseases and other cardiovascular diseases has been rising significantly, owing to various factors such as increasing obesity and sedentary lifestyles. This has led to an increase in the prevalence of heart diseases, which is likely to lead to an increase in endovascular procedures. In turn, this is expected to boost the hemostasis valves market.
• According to the 2016 Heart Disease and Stroke Statistics update of the American Heart Association (AHA), more than 15 million people over 20 years of age in the U.S. suffer from coronary heart disease (CHD).
• The incidence of coronary artery disease (CAD) has increased significantly in low-income and middle-income countries such as India. CAD accounts for 20% of the deaths in India.

Market in Asia Pacific to Expand at Rapid Pace

• North America held a major share of the global hemostasis valves market in terms of revenue in 2018. The region is anticipated to maintain its share during the forecast period. Advanced surgical techniques and the presence of leading players are estimated to boost the market in the near future. High disposable income and well-developed healthcare infrastructure are also augmenting the market in North America.
• Europe is anticipated to be the second-largest market in terms of share and revenue during the forecast period. Increase in the number of intervention procedures and rise in the geriatric population are expected to boost the hemostasis valves market in the region.
• The hemostasis valves market in Asia Pacific is estimated to expand at a CAGR of ~5% during the forecast period. Strong growth of the hemostasis valves market in the region can be ascribed to the presence of a significant patient pool and rapid adoption of technological advancements in Japan and China.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

Boston Scientific Corporation, B. Braun Melsungen AG, and Teleflex Incorporated – Leading Manufacturers of Hemostasis Valves

The report provides the profiles of leading players operating in the global hemostasis valves market. These include Boston Scientific Corporation Terumo Corporation, Merit Medical Systems, Inc., Freudenberg Medical, and ARGON MEDICAL.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

• Boston Scientific Corporation is one of the leading providers of hemostasis valves in the U.S. The company pursues strategic acquisitions, distribution, and similar arrangements in new and existing markets to achieve increased operating efficiencies, geographic diversification, and market penetration. In October 2016, Boston Scientific Corporation launched the Resolution 360 Clip, a hemostasis clip designed for more accurate clip placement, for the treatment of upper and lower gastrointestinal bleeding.
• In March 2018, Boston Scientific Corporation acquired EMcision Limited, a privately-held company operating in the U.S. and Canada. This acquisition is expected to enhance the company’s endoscopic portfolio with the inclusion of radiofrequency devices.
• Inorganic growth and partnerships are key strategies employed by leading players to expand their footprint in the market. This is anticipated to fuel the global hemostasis valves market in the near future.

Breast Reconstruction Market Future Opportunity Assessment 2019 - 2027

Transparency Market Research (TMR) has published a new report on the breast reconstruction market for the forecast period of 2019–2027. According to the report, the global breast reconstruction market was valued at ~ US$ 1.3 Bn in 2018, and is projected to expand at a CAGR of ~ 5% from 2019 to 2027. Rise in the prevalence of breast cancer, the launch of new products by companies, and the use of silicone breast implants & acellular dermal matrix for breast reconstruction are anticipated to augment the global breast reconstruction market from 2019 to 2027.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

Overview

• Rise in the prevalence of breast cancer, surge in the number of breast reconstruction procedures, and increase in the demand for acellular dermal matrix are expected to drive the global breast reconstruction market from 2019 to 2027.
• North America and Western Europe are likely to account for dominant shares of the global breast reconstruction market, owing to advancements in research & development and business expansion by various market leaders.
• However, product recalls in the market are likely to hamper the global breast reconstruction market.
• Asia Pacific is expected to be a highly lucrative market for breast reconstruction during the forecast period.

Rise in Prevalence of Breast Cancer to Propel Market

• The prevalence of breast cancer among women is increasing. After skin cancer, breast cancer has the highest prevalence among women across the globe. According to the World Cancer Research Fund International, nearly 2 million new cases of breast cancer were reported globally in 2018.
• Belgium, Luxembourg, and the Netherlands are the top three countries in Europe with the highest rate of breast cancer. According to data provided by the Continuous Update Project Panel of World Cancer Research Fund International, the consumption of alcoholic drinks is one of the primary causes of premenopausal breast cancer.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

Launch of New Products by Players to Augment Market

• Leading players in the global breast reconstruction market have launched new products such as silicone-filled breast implants, acellular dermal matrix, and tissue expanders. The usage of acellular dermal matrices in breast reconstruction has increased due to the rise in the awareness about single-stage breast reconstruction.
• For instance, in September 2018, Mentor Worldwide LLC launched the CPX4 Smooth Breast Tissue Expander in the U.S., thereby expanding the line of CPX4 Breast tissue expanders that can be used in prepectoral and submuscular breast reconstruction.

Product Recalls by Regulatory Authorities to Restrain Market

• Product recalls by regulatory authorities such as the Food and Drug Administration (FDA) and the National Agency for Medicines and Health Products Safety (ANSM) affect the revenue and market share of companies. In February 2014, ANSM recalled Cereform silicone gel-filled breast implants, as the sterilization process for the manufacture of the implant was not as per the set international standards.
• Additionally, in November 2014, the Therapeutic Goods Administration (TGA) suspended the sales of Cereform. Hence, product recalls are expected to restrain the breast reconstruction market during the forecast period.

Asia Pacific Breast Reconstruction Market to Witness Strong Growth

• In terms of revenue, the breast reconstruction market in Asia Pacific is projected to expand at a high CAGR during the forecast period. Factors driving the breast reconstruction market in the region are increase in awareness about breast reconstruction after mastectomy and use of acellular dermal matrix to support breast implants.
• Furthermore, geographic expansion & launch of new products by market players, product approvals in Japan and China, and increase in the number of women opting for breast reconstruction propel the breast reconstruction market in the region
• According to the American Society of Plastic Surgeons, in 2017, Japan reported the largest number of breast reconstruction procedures in Asia Pacific, accounting for 0.3% of the procedures performed, globally. Moreover, increasing focus on women’s health and availability of technologically-advanced medical devices for diagnostic and therapeutic purposes in countries such as China, India, and Australia are expected to boost demand for breast implants. This, in turn, is likely to augment the breast reconstruction market in Asia Pacific during the forecast period.

Competitive Landscape in Breast Reconstruction Market

• The report also provides the profiles of leading players operating in the global breast reconstruction market. These include Allergan, Mentor Worldwide LLC (Johnson & Johnson), Sientra, Inc., GC Aesthetics, Establishment Labs S.A., POLYTECH Health & Aesthetics GmbH, RTI Surgical, Inc., Groupe Sebbin SAS, Integra LifeSciences, and Wanhe.
• Increase in the sales of breast implants is an important factor for the key players in the market to generate high revenue. The development of customized breast implants and increase in research & development activities in biologics for breast reconstruction are anticipated to create significant opportunities in the breast reconstruction market.

Acute Kidney Injury Treatment Market Worldwide Major Trend Outlook 2019 - 2027

• The global acute kidney injury treatment market was valued at US$ 1,351.70 Mn in 2018. The global acute kidney injury treatment market is projected to expand at a compound annual growth rate (CAGR) of more than 7% from 2019 to 2027, according to a new report published by Transparency Market Research (TMR) , titled, ‘Acute Kidney Injury Treatment Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027′.
• The acute kidney injury treatment market report suggests that, increase in the geriatric population and rising incidences of acute kidney injuries are expected to propel the acute kidney injury treatment market. North America is expected to be a prominent region in the global acute kidney injury treatment market, owing to the rise in the patient population, high geriatric population, and increasing technological advancements.
• The acute kidney injury treatment market in Asia Pacific is expected to expand at a CAGR of around 8% during the forecast period, due to the increasing geriatric population, developing healthcare infrastructure, and growing patient population in the region.
• Moreover, research and development activities and initiatives by governments in the healthcare sector are anticipated to further enhance the acute kidney injury treatment market in Asia Pacific.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

Dialysis Segment Projected to be a Highly Lucrative Segment in the Acute Kidney Injury Treatment Market

• The dialysis segment accounted for a prominent share in the global acute kidney injury treatment market in terms of revenue in 2018. Dialysis facilitates the survival of critically ill patients with acute kidney injury.
• The number of dialysis centers has been increasing across the globe. This is anticipated to drive the dialysis segment in the acute kidney injury treatment market during the forecast period.
• According to the Centers for Medicare & Medicaid Services, there were 5,698 dialysis centers in the U.S. in 2010, as against 4,789 in 2005. Furthermore, the governments of emerging countries are setting up new dialysis centers and improving the existing ones.
• In 2013, Abu Dhabi Health Services Company and Abu Dhabi General Services Company announced a plan to establish a state-of-the-art dialysis center in Abu Dhabi, the UAE. This dialysis center would consist of 66 kidney dialysis units. Thus, the rise in the number of dialysis centers and related initiatives taken by governments are expected to offer immense opportunities to players operating in the acute kidney injury treatment market.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

Prerenal Acute Kidney Injury Segment Holds a Prominent Share in the Acute Kidney Injury Treatment Market

• In terms of type, the prerenal acute kidney injury segment held a leading share in the global acute kidney injury treatment market in 2018. It is anticipated to gain market share by the end of 2027, and expand at a CAGR of around 7.5% during the forecast period, in the acute kidney injury treatment market.
• Prerenal acute kidney injuries account for 55%-65% cases of acute kidney injury cases, while intrinsic acute kidney injuries constitute 25%-30% share. Around 5%-10% cases are of postrenal acute kidney injuries.

North America Holds Sway, whereas Asia Pacific Emerging as a Lucrative Market

• The North America region accounts for a key share in the global acute kidney injury treatment market, and is likely to witness further growth in the acute kidney injury treatment market. Rapidly growing geriatric population, growing patient population, strong ongoing clinical pipeline, and development for providing more advanced and efficient products are the prime factors responsible for the growth of North America acute kidney injury treatment market.
• Moreover, factors such as rising numbers of key players and their increasing acquisitions, mergers, and collaborations, growing government approvals for new products, accompanied with the rising adoption of advanced products are the factors boosting the growth of the acute kidney injury treatment market in North America.
• Asia Pacific is projected to be a rapidly expanding market in the global acute kidney injury treatment market during the forecast period, due to factors such as growing geriatric population, rising prevalence of chronic diseases which are more prone to develop acute kidney injury, rising urbanization, and increasing critical care admissions.
• Moreover, extensive government initiatives in the healthcare sector, increasing research and development, and growing presence and investments by global prime players in the Asia pacific region market are the factors responsible for the rapid growth of Asia Pacific in the global acute kidney injury treatment market.

Development of Technologically-Advanced Acute Kidney Injury Treatment Options and Strategic Collaborations and Acquisitions are Key Strategies Adopted by Leading Players 

• The report also provides the profiles of the leading players functioning in the global acute kidney injury treatment market. Angion Biomedica Corp., AM-Pharma, Quark Pharmaceuticals, Inc., Baxter International, Inc., Fresenius Medical Care AG & Co. KGaA., B. Braun Melsungen AG, Asahi Kasei Medical Co., Ltd., and LG Chem. are some of the key players functioning in the global acute kidney injury treatment market, accounting for a significant market share.
• Companies functioning in the acute kidney injury treatment industry are focusing on grow their geographic presence through developing promising molecules for acute kidney injury treatment, strategic acquisitions, mergers, and collaborations with acute kidney injury treatment market players in respective domains and geographies.
• Moreover, strong progressive research and development activities, product approvals, etc., are the factors due to which these players are experiencing growth in the acute kidney injury treatment market.

Adhesion Barriers Market | Trends, Share, Growth Rate, Opportunities and Market Forecast 2019 - 2027

Adhesion Barriers Market: Introduction

In terms of revenue, the global adhesion barriers market is projected to expand at a CAGR of ~ 7% during the forecast period, owing to numerous factors, regarding which, TMR offers thorough insights and forecasts in the adhesion barriers market report.

Adhesion barriers are medical implants used to prevent the formation of scarring or adhesion between tissues and organs following surgical procedures. Adhesion is formed between tissues and organs as the healing procedure begins after surgery. Adhesion could lead to severe medical complications such as post-surgical morbidity, chronic pelvic pain, bowel obstruction, and chronic abdominal pain. It is most commonly and frequently caused after abdominal and gynecological surgery.

Around 93% patients who undergo laparotomy surgical procedures develop adhesion. Several studies have indicated that, between 50% and 90% women undergoing gynecological surgery tend to develop post-operative intra-abdominal adhesion. In order to effectively deal with post-operative adhesion, several adhesion barriers have been developed during the past few years. The most commonly used adhesion barrier products include ADEPT, Gynecare Interceed, and Seprafilm. These are available in different formulations such as liquid, gel, and film.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

4DryField PH to be Highly Attractive

The report offers detailed segmentation of the global adhesion barriers market based on product, application, formulation, and end user. In terms of product, the Seprafilm segment is poised to account for a leading share of the global market during the forecast period, as it has been clinically proven to be effective at reducing post-operative adhesion. The 4DryField PH segment is anticipated to expand at a high CAGR during the forecast period.

4DryField PH is an adhesion barrier gel. 4DryField PH is the only product approved by the European Medicines Agency as a hemostatic agent as well as an adhesion barrier agent. It is commonly used for the prevention of adhesion in abdominal surgical procedures. The segment is estimated to witness strong growth in the adhesion barriers market due to an increase in the usage of the product for different types of abdominal surgeries. Hence, rise in the usage of adhesion barrier products is projected to drive the 4DryField PH segment in the adhesion barriers market during the forecast period.

High Number of Gynecological Surgeries and Neurosurgeries to Propel Market

In terms of application, the global adhesion barriers market has been segregated into gynecological surgeries, abdominal surgeries, and neuro & orthopedic surgeries. The abdominal surgeries segment dominated the global adhesion barriers market in 2018. A large share of the segment can be ascribed to the high number of abdominal surgeries in highly populated countries such as India and China, increase in awareness about surgical adhesions in the region, and high adoption of abdominal adhesion prevention products in Japan.

However, the neuro & orthopedic surgeries segment is projected to expand at a high CAGR of ~ 9% during the forecast period, due to an increase in the number of neurosurgeries across the globe. For instance, a study published in the Journal of Neurosurgery (2018) concluded that, 1,756,891 patients require neurosurgical operations in Europe. The gynecological surgeries segment is likely to be a highly lucrative segment of the adhesion barriers market during the forecast period, owing to the rise in adhesion-related gynecological surgeries across the world. According to research studies, the adhesion rate for gynecological and C-section surgeries stands at around 94%, while that for adhesiolysis and gastrointestinal surgeries ranges from 65% to 75%.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

Film Formulation to Account for a Prominent Share

In terms of formulation, the film segment is expected to dominate the global adhesion barriers market during the forecast period. Increase in the sales of film-based products is anticipated to drive segments such as Seprafilm and Gynecare Interceed, as these are widely used for abdominal and gynecological surgeries. The liquid segment is estimated to expand at a high CAGR during the forecast period, due to an increase in the adoption and usage of ADEPT adhesion barrier solutions across the globe.

Hospitals – Prominent End User

Based on end user, the hospitals segment is estimated to constitute a dominant share of the global adhesion barriers market from 2019 to 2027. A large share of the segment can be ascribed to the high number of abdominal surgeries that are performed in hospital settings. The ambulatory surgical centers segment is also projected to be a key segment of the adhesion barriers market during the forecast period. The segment is likely to expand at a high CAGR from 2019 to 2027 in the adhesion barriers market.

Global Adhesion Barriers Market: Prominent Regions

Asia Pacific to Create High Incremental Opportunity

In terms of revenue, North America is projected to dominate the global adhesion barriers market from 2019 to 2027. This can be ascribed to the early adoption of technologically-advanced adhesion barrier products, favorable health care reimbursement policies in the U.S. and Canada, and increase in the number of surgeries in the U.S. More than 9 million abdominal and pelvic surgeries in the U.S. and over 30 million abdominal and pelvic surgeries are performed, every year. Furthermore, around 1.5 million spine surgeries in the U.S. and around 3.5 million spine surgeries are performed every year.

Europe was a key market for adhesion barriers in 2018. According to a study published in Eurostat in 2018, in the European Union, life expectancy has increased by more than two years per decade since the 1960s, to 84 years in 2016 for women. Increase in the geriatric women population results in a rise in gynecological disorders. Hence, the rise in gynecological disorders in geriatric women is expected to drive the adhesion barriers market in Europe during the forecast period. The adhesion barriers market in Asia Pacific is anticipated to expand at a high CAGR during the forecast period, due to the rise in the adoption of adhesion barrier products and high number of gynecological and abdominal surgeries in countries such as China, India, South Korea, and Hong Kong.

Partnerships & Collaborations and New Product Developments & Launches in International Market – Key Trends among Leading Players

The report provides profiles of the leading players operating in the global adhesion barriers market. Baxter International, Inc., Ethicon US, LLC, FzioMed, Inc., Sanofi, and Integra LifeSciences Corporation are the prominent players operating in the adhesion barriers market. These players have adopted strategies such as partnerships & collaborations and new product developments & launches to increase their market presence. In October 2018, FzioMed announced the launch of a new adhesion barrier product – Oxiplex. It is an adhesion barrier gel that is used during an intrauterine surgery.

Laboratory Gas Generators Market Dynamics, Forecast, Analysis and Supply Demand 2019 - 2027

Transparency Market Research (TMR) has published a new report on the laboratory gas generators market for the forecast period of 2019–2027. According to the report, the global laboratory gas generators market was valued at ~ US$ 2.9 Bn in 2018, and projected to expand at a CAGR of ~ 5.5% from 2019 to 2027.

Laboratory Gas Generators Market: Overview

• Expansion of the healthcare industry, increase in research and development expenditure, government initiatives, and rise in product approvals are projected to augment the global laboratory gas generators market between the period of 2019 to 2027.
• North America and Western Europe are likely to account for prominent shares of the global laboratory gas generators market, owing to advancements in research and development and business expansion by various market leaders.
• However, lack of technical and skilled personnel for overall operations in the market is likely to hamper the global laboratory gas generators market in North America during the latter half of the forecast period. Asia Pacific is expected to be a highly lucrative market for laboratory gas generators during the forecast period.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

Increasing Adoption of Analytical Instruments, Systems, and Methods for Research Activities to Drive Market

• Analytical instruments, systems, and methods are required in healthcare & related industries in large numbers, owing to wide applications in these industries for various laboratory gas generators.
• Laboratory gas generators are utilized in various industries for applications such as chromatography and mass spectroscopy for research activities, diagnosis, detection, and other analytical purposes.
• Laboratory gas generators require different gasses such as nitrogen, hydrogen, oxygen, and zero air. Internal gas generation by laboratory gas generators make these analytical procedures easy and convenient. Furthermore, the gas generators market is also expanding due to a rise in the adoption of these analytical instruments & systems.

Lack of Technical and Skilled Personnel for Overall Operations to Restrain the Laboratory Gas Generators Market

• Lack of medical personnel in certain regions has led to increasing burden on their governments to provide better healthcare and clinical laboratory facilities and services to people. This acts as a major restraint of the global laboratory gas generators market.
• Key players operating in the laboratory gas generators market are experiencing hurdles such as lack of skilled labor who are able to explain the technical specifications to end users across emerging economies.
• This lack of personnel in gas generator installation, maintenance, services, and technical expertise restrains the global laboratory gas generators market.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

Pharmaceutical & Biotechnology Companies Promising End Users

• In terms of end user, the global laboratory gas generators market has been divided into chem/petrochemical companies, pharmaceutical & biotechnology companies, environmental companies, food and beverage companies, and others.
• The pharmaceutical & biotechnology companies segment is expected to be a highly lucrative segment of the global laboratory gas generators market during the forecast period. Laboratory gas generators are vital for pharmaceutical and biotechnology companies to provide high level of purity for various applications, ranging from the manufacturing to packaging of drugs.

North America a Prominent Laboratory Gas Generators Market

• In terms of region, the global laboratory gas generators market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America dominated the global laboratory gas generators market in 2018, followed by Europe.
• North America accounted for a major share of the global laboratory gas generators market in 2018, owing to the increase and early adoption of innovative chromatic techniques in biotechnology and pharmaceutical industries, rise in the need for research into new drugs and industrial products, well-established healthcare infrastructure, and the presence of major players in the region.
• According to a 2018 report by the Council of Economic Advisers, an agency within the executive branch, the U.S. funds nearly half of the world’s medical research and development.
• The laboratory gas generators market in Asia Pacific is projected to expand at a high CAGR from 2019 to 2027. This can be attributed to developing countries with significant potential for research and development in various sectors in the region.

Competitive Landscape of Laboratory Gas Generators Market

• Parker Hannifin Corp. and PerkinElmer, Inc. leads the global laboratory gas generators market.
• The global laboratory gas generators market is fragmented in terms of number of players. Key players in the global market include Parker Hannifin Corp, Angstrom Advanced, Inc., PerkinElemer, Inc., Peak Scientific Instruments Ltd., Nel ASA, Erre Due s.p.a., Nitrogenium, F-DGSi, and Airgas, Inc. Wide distribution network, new product development, and mergers & acquisitions are the key strategies followed by these major players in order to sustain in the global laboratory gas generators market.

DNA Test Kits Market Overview by Increasing Demand and Sales 2019 - 2027

Transparency Market Research (TMR) has published a new report titled,“DNA Test Kits Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”. According to the report, the global DNA test kits market was valued at US$ 747.0 Mn in 2018 and is projected expand at a CAGR of 23.4% from 2019 to 2027. Increase in demand for DNA kits for ancestry testing, Increasing awareness among people regarding use of DNA test kits for disease risk assessment and rise in popularity of direct-to-consumer testing are anticipated to drive the global DNA test kits market.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

Increase in Demand for Ancestry Testing to Drive Market

• Demand for ancestry testing using saliva-based or cheek swab DNA test kits is rising in the developed countries in North America and Europe. There is rapid increase in the number of users of DNA test kits for ancestry and health & fitness. The number of people interested in knowing about their ancestors and family tree has increased is also anticipated to increase the demand for DNA test kits, especially in developed countries across the globe
• Moreover, increase in number of applications of direct-to-consumer genetic testing and rise in demand for DNA testing for health & fitness are the other factors anticipated to drive the DNA test kits market
• During Christmas and Black Friday, companies offer high discounts and offers on DNA testing services and people gift DNA test kits to their relatives. Furthermore, companies offer diet, health & fitness for free or as a part of subscription leading to increase in number of customers using DNA test kits. Therefore, boom in ancestry testing in North America is likely to boost the growth of the DNA test kits market.
• Key players in the global DNA test kits market such as DNAFit and My Inner Go offer a number of DNA testing services to meet the demand for DNA test kits for fitness. These provide tailored fitness and weight management advice to the customers.
• Additionally, strategic approaches such as product launch, marketing efforts, distribution agreements and others are anticipated to propel the global DNA test kits market

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

Asia Pacific Offers Significant Opportunities

• Along with the U.S., the DNA test kits market is booming in countries such as China and Japan. These genetic tests have become popular through social media and other online platforms. This is anticipated to boost the growth of the DNA test kits market.
• Recent acquisitions by companies in China have supported the growth of DNA test kits market in the region. For instance, Prenetics acquired DNAFit in April 2018.
• Moreover, people are concerned about increase in lifestyle diseases such as obesity and diabetes. Rise in awareness about preventive care measures to tackle the burden of diseases has led to an increase in the number of people interested in DNA test kits for diet & nutrition and health & fitness.
• Other factor driving the DNA test kits market in the region is increase in knowledge about processing and analysis of DNA sample by the companies
• Furthermore, a number of startups in China and Japan have launched new products for fitness testing considering an increase in genetic testing for diet and fitness

New Product Launch and Strengthening Distribution Channels: Key Strategies Adopted by Key Players in DNA Test Kits Market

• The report also provides profiles of leading players operating in the global DNA test kits market. These include Ancestry, 23andMe, Inc., MyHeritage Ltd., Gene by Gene, Ltd., Living DNA Ltd., National Geographic Partners, LLC, Helix OpCo, LLC, Veritas, FitnessGenes, and EasyDNA.
• The leading companies in the global DNA test kits market are focused on strengthening distribution channel and product portfolio expansion to gain market share. In November 2018, Helix OpCo, LLC launched a new DNA test kits for ancestry and wellness DNA testing with customer access to two embedded apps, Ancestry Basics and Wellness Basic.
• In August 2016, Ancestry entered into a collaboration with Quest Diagnostics to expand consumer DNA test kits portfolio and expand its presence in DNA test kits market

Canes and Crutches Market Analysis 2019 - 2027, Major Key Players Reviews

Transparency Market Research (TMR)  has published a new report titled, “Canes and Crutches Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027”. According to the report, the global canes and crutches market was valued at US$ 860 Mn in 2018 and is projected to expand at a CAGR of 4.0% from 2019 to 2027.

Overview

• Growth of the global canes and crutches market is attributed to increase in the global geriatric population. Moreover, factors such as increase in the number of people with disabilities and rise in prevalence of arthritis & osteoporosis boost the growth of the global canes and crutches market.
• Europe dominated the global canes and crutches market in 2018 and the trend is anticipated to continue during the forecast period. This is attributed to increase in the number of people with disabilities and favorable reimbursement scenario in the region.
• However, increase in the number of local manufacturers creating pricing pressure in the market is likely to hamper the growth of the global canes and crutches market in Europe. Asia Pacific is expected to be a highly lucrative market for canes and crutches during the forecast period.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

Increase in Global Geriatric Population and Rise in Population with Disabilities to Drive Market

• Increase in the global geriatric population is a major factor driving the global canes and crutches market. Aging is associated with declining support for long-term caregiving. The global population is aging rapidly and will require canes and crutches in order to maintain stability while walking.
• According to the United Nations, the geriatric population aged 60 years and above is expected to double by 2050, and triple by 2100, increasing from 962 million in 2017 to 2.1 billion in 2050 and 3.1 billion in 2100. Moreover, rise in the number of individuals with disabilities contributes to the growth of the global canes and crutches market.
• Additionally, rise in prevalence of arthritis & osteoporosis, grants from governments, and various initiatives taken for the disabled by international organizations fuel the growth of the global canes and crutches market across the world.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

Canes Segment to Dominate Market

• In terms of product, the global canes and crutches market has been segmented into canes and crutches. The canes segment dominated the global canes and crutches market in 2018 and the trend is likely to continue during the forecast period. It is projected to be a highly lucrative segment from 2019 to 2027, as canes are less costly and easy to transport. The quad canes sub-segment dominated the canes segment in 2018 because these offer better stability on the floor or stairs. Folding canes is projected to be a less attractive sub-segment due to high prices.
• The axillary crutches sub-segment dominated the crutches segment in terms of share in 2018. However, the sub-segment is anticipated to lose market share due to limitations such as damage of axillary vein during the forecast period.

Online Stores to be Promising Segment

• In terms of distribution channel, the global canes and crutches market has been segmented into hospital pharmacies, medical retail stores, and online stores
• Online stores is expected to be a highly lucrative segment during the forecast period. The segment is likely to be driven by increase in popularity of online purchase and better discount rates available on these stores.
• The medical retail stores segment held major market share in 2018. The segment is expected to sustain market share during the forecast period owing to rise in the number of medical retail stores and easy availability of canes and crutches in these stores.

Europe to Dominate Global Market

• Geographically, the global canes and crutches market has been segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Europe dominated the global canes and crutches market in 2018, followed by North America. Europe accounted for major share of the global canes and crutches market in 2018 owing to large number of people with disabilities and increase in the geriatric population.
• The canes and crutches market in Asia Pacific is projected to expand at a high CAGR from 2019 to 2027. This can be attributed to increase in the geriatric population in countries such as Japan and China, and rise in health care expenditure in the region.

Competitive Landscape

• Drive DeVilbiss Healthcare and Cardinal Health, Inc. lead the global canes and crutches market
• The global canes and crutches market is fragmented in terms of number of players. Key players in the global market include Drive DeVilbiss Healthcare, Cardinal Health, Inc., Medline Industries, Inc., GF Health Products, Inc., NOVA Medical Products, Invacare Corporation, Ergoactives, and Sunrise Medical. Drive DeVilbiss Healthcare and Cardinal Health, Inc. are the leading players in the global market. Wide distribution network, new product development, and merger & acquisitions are the key business strategies followed by these major players. 

Electrophysiology Devices Market : Trend, CAGR Status, Growth, Analysis and Forecast to 2027

The global electrophysiology devices market was valued at US$ 5,271 Mn in 2018. The global electrophysiology devices market is projected to register a cumulative annual growth rate (CAGR) of more than 8% from 2019 to 2027, according to a new report published by Transparency Market Research (TMR) titled, ‘Electrophysiology Devices Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027′.

Expansion of the healthcare industry, increase in healthcare expenditure, government initiatives, rise in product approvals, and increase in patient population are projected to augment the global electrophysiology devices market from 2019 to 2027. North America and Western Europe are likely to account for prominent shares in the global electrophysiology devices market, owing to the advancements in healthcare and products, and business expansion by various electrophysiology devices market leaders.

Development of healthcare infrastructure and high medical expenditure by governments in emerging markets such as China and India are likely to boost the electrophysiology devices market in Asia Pacific at a CAGR of around 9.0% from 2019 to 2027.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

Rising Incidences of Cardiac Arrhythmias Expected to Propel the Electrophysiology Devices Market

Arrhythmias is a major indication for the need of an electrophysiology examination. Globally, rising incidences of different types of arrhythmias, such as atrial fibrillation, atrial flutter, ventricular tachycardia, and atrial tachycardia, are playing key roles in boosting the electrophysiology devices market.

The geriatric population, and people with high blood pressure, diabetes, obesity, and other cardiovascular diseases are at high risk of developing arrhythmias. This factor is likely to boost the electrophysiology devices market.

• According to the National Center for Biotechnology Information (NCBI), Center for Disease Control and Prevention (CDC), and the ‘Sign Against Stroke in Atrial Fibrillation’ campaign, atrial fibrillation is a highly common arrhythmia, which affected more than 2.6 million people in the U.S., around 6 million in Europe, and nearly 8 million in China, in the year 2016.
• It has been predicted that this toll is likely to increase 2.5 times by 2050, due to the influence of the globally rising geriatric population and changing lifestyle-related diseases. These factors are expected to boost the demand for electrophysiology devices at present, as well as in the near future. 

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

Technological Advancements to Boost the Electrophysiology Devices Market

Significant technological advancements in the field of electrophysiology devices have dramatically changed the way physicians treat their patients, leading to improved outcomes. Minimally invasive surgeries offer shorter hospital stay, minimal incision, less post-surgery complications, and shorter recovery time. Pacemaker lead is a major factor causing complications in patients implanted with pacemakers.

• Nanostim, Inc. addressed this issue by producing a leadless pacemaker, the size of a pen tip, which is implanted with the help of a catheter. The introduction of other advanced electrophysiological products, such as MRI-compatible pacemakers, irrigated-tip catheters, 3D mapping systems, real-time digital Holter monitors, and steerable curve diagnostic catheters, has further enhanced the productivity of electrophysiology treatment, ultimately boosting the electrophysiological devices market.
• Hence, increasing technological advancements and growing demand for minimally-invasive surgeries attract patients and help manufacturers increase patient throughput.

Lack of Reimbursement Policies Restraining the Electrophysiology Devices Market

• Electrophysiology devices are extensively utilized; however, there are no reimbursement policies for electrophysiology devices. This is a matter of concern, especially in developing countries where there are large patient pools that cannot afford electrophysiology devices.
• Lack of reimbursement policies for a necessary devices, such as these, directly affects the sales of electrophysiology devices. For instance, the sales of Terumo Corporation’s micro guide catheters declined in Japan due to changes in the reimbursement policies concerning these catheters. Moreover, high volume of product recalls of Medtronic’s micro guide catheters in 2016 was a major setback for the global electrophysiology devices market.

Asia Pacific Market to Expand Significantly

• The electrophysiology devices market in Asia Pacific is anticipated to expand at an impressive CAGR during the forecast period. The electrophysiology devices market in Asia Pacific is estimated to expand at a CAGR of around 9.0% during the forecast period. India, China, and Japan are expected to drive the electrophysiology devices market in Asia Pacific.
• The increasing prevalence of cardiovascular diseases in countries such as India and China, increasing awareness regarding early diagnosis, and improving economic conditions are expected to fuel the electrophysiology devices market.

Prominent Electrophysiology Devices Market Players – Biosense Webster, Inc., Abbott, Medtronic plc, and Boston Scientific Corporation

The electrophysiology devices market report also provides the profiles of leading players operating in the global electrophysiology devices market. These include Biosense Webster, Inc., Abbott, Medtronic plc, and Boston Scientific Corporation. Increase in mergers & acquisitions, strategic collaborations, and new product launches are expected to drive the global electrophysiology devices market during the forecast period. Additionally, strong product portfolio, high brand recognition, and strong geographic presence are expected to boost the electrophysiology devices market during the forecast period.

Surgical Microscopes Market: Precise Analysis on Business Overview, Product Scope And Ongoing Market Development 2027

Surgical Microscopes Market: Introduction

Transparency Market Research has published a new report on the surgical microscopes market. According to the report, the global surgical microscopes market was valued at ~US$ 515 Mn in 2018. It is expected to expand at a CAGR of ~10% during the forecast period of 2019 to 2027.

An operating or surgical microscope is an optical instrument that provides the surgeon with a stereoscopic, high quality magnified, and illuminated image of small structures in the surgical area. The operating microscope is a fixture of modern surgical facilities, and it is critically important for the success of several complex surgical interventions that are used today.

First used in neurosurgical procedures, surgical microscopes are now heavily utilized in the surgical practices of ophthalmology, otolaryngology, plastic and reconstructive medicine, dentistry, gynecology, oncology, urology, etc. The purpose of a surgical microscope is to improve the surgeon’s view and also improve the usual components of microscopy, magnification, resolution, and illumination. Modern surgical microscopes can be placed on a stand, table or even worn by the surgeon. These microscopes can also be mounted on the ceiling or a wall to conserve floor space in the surgical suite.

Want to know the obstructions to your company’s growth in future? Request a PDF sample here

In terms of product, the on casters segment held a major share of the global surgical microscopes market in 2018. It is likely to maintain its dominance during the forecast period, owing to their increased penetration in the market, and also because they provide ease of operation and maneuverability. Based on application, the oncology segment is estimated to account for a major share of the global surgical microscopes market. This segment is anticipated to expand at a rapid pace during the forecast period. According to the National Cancer Institute, in 2016, there were an estimated 15,338,988 people living with cancer in the U.S. In terms of end user, the hospitals & ambulatory surgical centers segment is anticipated to dominate the global surgical microscopes market during the forecast period, due to an increase inpatient admissions in hospitals and ambulatory surgical centers.

Surgical microscopes are used in various surgeries such as ENT surgeries, neurosurgery, dental surgeries, etc. Surgical microscopes, along with technological advancements, provide surgeons with better insights, enabling appropriate decision-making regarding the treatment procedure. However, the high cost of procurement of surgical microscopes and lack of skilled professionals are factors that are expected to hamper the growth of the surgical microscopes market during the forecast period.

Global Surgical Microscopes Market: Prominent Regions

North America holds a major share of the global surgical microscopes market. The market in the region is estimated to expand at a rapid CAGR during the forecast period. It is primarily driven by factors such as highly structured healthcare industry and availability of well-defined reimbursement policies from private and public health insurance firms. In addition, the adoption of new technologies related to surgical microscopes, along with high awareness among people about diseases and related cure & technologies, and a large number of players in the North American region focusing on R&D activities to introduce technologically-advanced surgical microscopes with improved design are driving the surgical microscopes market in the region.

To Obtain All-Inclusive Information On Forecast Analysis Of Global Market, Request A PDF Brochure Here.

The surgical microscopes market in Asia Pacific is estimated to witness significant growth. Asia Pacific is a relatively untapped market as compared to developed regions. Hence, the region offers immense growth opportunities to market players. Factors such as high prevalence of chronic diseases, rise in geriatric population resulting in increased number of surgeries, surge in patient population, and growth of the healthcare industry in the region are factors fueling the expansion of the surgical microscopes market in the region.

Europe held the second-largest market share in 2018. Well-developed healthcare infrastructure and increase in the number of surgical procedures are driving the surgical microscopes market in the region. This markets in the Middle East & Africa and Latin America are projected to witness moderate growth in the near future.

Global Surgical Microscopes Market: Key Players

Key players are expanding their footprint to strengthen their position in the global surgical microscopes market. Emerging economies, due to an increase in the number of patient population and surgical procedures, offer lucrative opportunities to key players to increase their market share. Manufacturers are engaging in new product development, collaborations, acquisitions, and distribution agreements. For instance, In March 2018, The Metall Zug Group completed 70% acquisition of HAAG-STREIT GROUP, headquartered in Köniz, Switzerland. Haag-Streit Holding AG develops, produces, and distributes high-quality products and services for diagnosis and surgery, mainly in the fields of ophthalmology and surgical microscopy. Following this acquisition on February 28, 2018, Haag-Streit Holding AG formed the fourth Business Unit Medical Devices of the Metall Zug Group.

Prominent players operating in the global surgical microscopes market are ZEISS International, Leica Microsystems (Subsidiary of Danaher), HAAG-STREIT GROUP (Metall Zug Group), TOPCON CORPORATION, Alcon, Takagi Ophthalmic Instruments Europe Ltd., Ecleris, Optomic, Seiler Instrument Inc., and ATMOS MedizinTechnik GmbH & Co. KG.

Telemedicine Market Worldwide Major Trend Outlook 2014 - 2020

The global telemedicine market is prognosticated to grow in upcoming years owing to several factors. The market includes big and small players, which market the scenario highly competitive. The key players in the global telemedicine market include InTouch Technologies, Inc., Allscripts Healthcare Solutions, Inc., CISCO Systems, Inc., Siemens Healthcare, and Honeywell HomMed LLC,. The major players are likely to capitalize on the growing economies so as to benefit from the untapped market potential.

The global telemedicine market was expected to flourish at a robust CAGR of 14.5% within the forecast period from 2014 to 2020. In 2013, the market was evaluated to be of worth around US$14.3 bn. This value is expected to rise around worth of US$36.3 bn by the end of 2020.Thus, the market is expected to showcase a lucrative potential for the market players in the forthcoming years.

Request Sample @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3032

Based on specialty, dermatology segment is foreseen to excel among others in terms of revenue in the global telemedicine market. This is credited to the rising cases related to dermatology in the market and rise in number of people who are now more beauty conscious. On the basis of geography, North America region is anticipated to dominate the global telemedicine market trailed by Asia Pacific. The latter’s progress is attributed to supportive government policies and increase in population in urban and rural areas.

Rising Trend of Monitoring Remote Patients to Fuel Market Demand

Telemedicine market has gained a lot of traction in the remote management of the patients post treatment of chronic illnesses. Telemedicine the service where the healthcare related issues are dealt over teleconference or telecommunication, for example, consultation. This helps the medical practitioners to analyze, diagnose, treat the patients, and prescribe medicines. The global telemedicine market is stimulated by increase in trend of monitoring remote patients, healthcare expenses, advancement in technology, and increased cases of chronic illnesses. However, there are certain hindering factors as well in the market that are foreseen to slow down the growth in future, such as, requirement of high initial capital, poor cases of telemedicine implementation, inappropriate reimbursement policies, and lack of skilled labors.

Request Brochure @ 

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3032

Risk of Violation of Privacy and Security Laws to Hinder Market Growth

Moreover, while the patient are communicated through telehealth, there is a high risk to violate the security and privacy laws. Since such interactions include communication with the patients that are not present physically, there is also a risk to disclose the unrequired information to the wrong person, which comes under the unauthorized disclosure of information as per HIPAA Privacy Rule. To reduce such incidences, the telehealth providers need to have a strong and reliable ways to authenticate and verify the doctor’s as well as patient’s identity at the time of every telehealth practice. In the present market scenario, there is a shortage of such ways for identity authentication. Telehealth encounters are as well estimated to be vulnerable to signal errors, third-party interference, and interrupted transmission. Such cases are expected to resultant in interrupted communication, loss of data, alteration of important medical instructions, which along with other risks are foreseen to lead to HIPAA security and privacy violations.